Reckitt Benckiser Group PLC
Company Profile
Business description
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded as Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold a number-one or -two position in their categories globally. Reckitt has repositioned its portfolio; it entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating over 40% of core sales from emerging markets.
Contact
103-105 Bath Road
SloughBerkshireSL1 3UH
GBRT: +44 1753217800
Sector
Consumer Defensive
Stock type
Defensive
Industry
Household & Personal Products
Fiscal Year End
31 December 2026
Employees
36,200
Reckitt Benckiser Group PLC News & Analysis
stocks
3 wide moat shares at five-star prices
stocks
Brexit: worst-case scenario hits British bank and supermarket stocks
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,971.40 | 2.60 | 0.03% |
| CAC 40 | 7,889.60 | 2.46 | 0.03% |
| DAX 40 | 25,692.22 | 101.45 | 0.40% |
| Dow JONES (US) | 52,538.00 | 160.43 | 0.31% |
| FTSE 100 | 10,691.02 | 4.48 | 0.04% |
| HKSE | 23,094.83 | 53.51 | 0.23% |
| NASDAQ | 26,469.74 | 8.07 | -0.03% |
| Nikkei 225 | 63,954.19 | 685.82 | 1.08% |
| NZX 50 Index | 13,691.33 | 11.06 | 0.08% |
| S&P 500 | 7,738.53 | 15.93 | 0.21% |
| S&P/ASX 200 | 8,847.30 | 2.80 | -0.03% |
| SSE Composite Index | 3,681.47 | 33.17 | 0.91% |